Related Experiment Video

Updated: May 19, 2026

Selective Depletion of Microglia from Cerebellar Granule Cell Cultures Using L-leucine Methyl Ester
08:10

Selective Depletion of Microglia from Cerebellar Granule Cell Cultures Using L-leucine Methyl Ester

Published on: July 7, 2015

Deprive to kill: glutamine closes the gate to anticancer monocarboxylic drugs

Simone Cardaci1, Maria Rosa Ciriolo

  • 1Department of Biology, University of Rome Tor Vergata, Rome, Italy.

Autophagy
|August 31, 2012
PubMed

Insights

Depriving cancer cells of glutamine enhances the antitumor effects of 3-bromopyruvate by increasing its uptake. This metabolic strategy improves drug selectivity for malignancies in clinical settings.

Area of Science:

  • Biochemistry
  • Oncology
  • Cancer Cell Metabolism

Background:

  • Antitumor drug efficacy can be improved by targeting cancer cell biochemical adaptations.
  • Glutamine deprivation is a potential strategy to enhance anticancer effects.
  • 3-bromopyruvate is an alkylating analog of pyruvic acid that induces autophagic cell death via metabolic-oxidative stress.

Purpose of the Study:

  • To investigate how glutamine withdrawal affects the antitumor properties of 3-bromopyruvate.
  • To determine the mechanism by which glutamine deprivation enhances 3-bromopyruvate efficacy.
  • To establish a metabolic condition for increasing the selectivity of 3-bromopyruvate in neoplastic tissues.

Main Methods:

  • Cancer cell culture and metabolic manipulation.
  • Assessment of 3-bromopyruvate uptake and intracellular concentration.
  • Analysis of monocarboxylate transporter 1 (MCT1) expression and regulation.
  • Evaluation of cell death induction and antitumor effects.

Main Results:

  • Glutamine withdrawal significantly enhanced the antitumor effects of 3-bromopyruvate.
  • This enhancement was mediated by increased intracellular uptake of 3-bromopyruvate.
  • Glutamine deprivation led to a post-transcriptional increase in monocarboxylate transporter 1 (MCT1) expression.
  • Increased MCT1 expression facilitated greater 3-bromopyruvate delivery into cancer cells.

Conclusions:

  • Modulating glutamine availability is a viable strategy to enhance the efficacy and selectivity of 3-bromopyruvate.
  • Targeting cancer cell metabolism, specifically glutamine, can improve the clinical application of monocarboxylic antitumor drugs.
  • This approach offers a novel strategy for targeting malignancies by optimizing drug delivery and action.

More Related Videos

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts06:32

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts

Published on: April 13, 2022

Glutamine Flux Imaging Using Genetically Encoded Sensors10:23

Glutamine Flux Imaging Using Genetically Encoded Sensors

Published on: July 31, 2014

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...